SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-24-003136
Filing Date
2024-05-28
Accepted
2024-05-28 17:04:51
Documents
16
Period of Report
2024-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_052824.htm   iXBRL 8-K 23972
2 EXHIBIT 10.1 exh_101.htm EX-10.1 122661
3 PRESS RELEASE exh_991.htm EX-99.1 11194
  Complete submission text file 0001171843-24-003136.txt   398182

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3003
5 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25598
6 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 34011
7 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 22139
19 EXTRACTED XBRL INSTANCE DOCUMENT f8k_052824_htm.xml XML 3317
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 24992908
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)